Comparative Dosimetry for ^sup 68^Ga-DOTATATE: Impact of Using Updated ICRP Phantoms, S Values, and Tissue-Weighting Factors

• Published in: The Journal of nuclear medicine (1978) Vol. 59; no. 8; p. 1281
• Main Authors: Josefsson, Anders, Hobbs, Robert F, Ranka, Sagar, Schwarz, Bryan C, Plyku, Donika, de Carvalho, Jose Willegaignon de Amorim, Buchpiguel, Carlos Alberto, Sapienza, Marcelo Tatit, Bolch, Wesley E, Sgouros, George
• Format: Journal Article
• Language: English
• Published: New York Society of Nuclear Medicine 01.08.2018
• Subjects: Adrenal glands; Bladder; Brain; Brain tumors; Coefficients; Computational neuroscience; Computed tomography; Diagnostic agents; Diagnostic systems; Dosimeters; Dosimetry; Drug dosages; Electron transport; Gastrointestinal tract; Kidneys; Liver; Lungs; Mathematical analysis; Medical imaging; Muscles; Neuroendocrine tumors; Neuroimaging; Organs; Pituitary; Pituitary gland; Positron emission; Positron emission tomography; Radiation therapy; Receptors; Salivary gland; Salivary glands; Somatostatin; Somatostatin receptors; Spleen; Stem cells; Thigh; Thyroid; Thyroid gland; Tissue engineering; Tomography; Unit activity; Urinary bladder; Weighting

The data that have been used in almost all calculations of MIRD S value absorbed dose and effective dose are based on stylized anatomic computational phantoms and tissue-weighting factors adopted by the International Commission on Radiological Protection (ICRP) in its publication 60. The more anatom...